Are Investors Undervaluing Coloplast AS By 38 - Simply Wall St
| CLPBY Stock | USD 9.60 0.10 1.05% |
Slightly above 51% of Coloplast's investor base is interested to short. The analysis of overall sentiment of trading Coloplast A pink sheet suggests that many investors are impartial at this time. Coloplast's investing sentiment can be driven by a variety of factors including economic data, Coloplast's earnings reports, geopolitical events, and overall market trends.
Coloplast |
Are Investors Undervaluing Coloplast AS By 38 Simply Wall St
Read at news.google.com
 |
Coloplast Fundamental Analysis
We analyze Coloplast's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Coloplast is rated fifth in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Coloplast A Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coloplast pink sheet to make a market-neutral strategy. Peer analysis of Coloplast could also be used in its relative valuation, which is a method of valuing Coloplast by comparing valuation metrics with similar companies.
Peers
Coloplast Related Equities
| CZMWF | Carl Zeiss | 7.90 | ||||
| ESLOY | Essilor International | 2.82 | ||||
| ESLOF | EssilorLuxottica | 2.65 | ||||
| SAUHY | Straumann Holding | 2.31 | ||||
| CLPBY | Coloplast | 1.05 | ||||
| BDX | Becton Dickinson | 0.76 | ||||
| POCI | Precision Optics, | 0.66 | ||||
| CLPBF | Coloplast A/S | 0.02 | ||||
| SSMXY | Sysmex Corp | 0.35 |
Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.